Serum Chemokines RANTES and Monocyte Chemoattractant Protein-1 in Egyptian Patients with Atopic Asthma: Relationship to Disease Severity

Archives of Medical Research

Volumn 43, Issue 1, 2012, Pages 36-41

  Saad El Din Bessa, Sahar ^a   Abo El Magd, Gehan Hassan ^a   Mabrouk, Maaly Mohamed ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Asthma; Chemokines; MCP 1; RANTES; Severity

Indexed keywords

BRONCHODILATING AGENT; IMMUNOGLOBULIN E; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STEROID;

ADULT; AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EGYPT; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SPIROMETRY;

ADULT; ASTHMA; BIOLOGICAL MARKERS; BLOOD CELL COUNT; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINE CCL5; EGYPT; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED;

EID: 84859225639     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.01.009     Document Type: Article

References (55)

1. Maddox L., Schwartz D.A. The pathophysiology of asthma. Annu Rev Med 2002, 53:477-498.
2. Sengler C., Lau S., Wahn U., et al. Interactions between genes and environmental factors in asthma and atopy: new developments. Respir Res 2002, 3:7.
3. Luster A.D. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 338:436-445.
4. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
5. Baggiolini M., Dahinden C.A. CC chemokines in allergic inflammation. Immunol Today 1994, 15:127-133.
6. Teran L.M., Davies D.E. The chemokines: their potential role in allergic inflammation. Clin Exp Allergy 1996, 26:1005-1019.
7. Alam R. Chemokines in allergic inflammation. J Allergy Clin Immunol 1997, 99:273-277.
8. Homey B., Zlotnik A. Chemokines in allergy. Curr Opin Immunol 1999, 11:626-634.
9. Teran L.M. CCL chemokines and asthma. Immunol Today 2000, 21:235-242.
10. Bisset L.R., Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective. Curr Opin Pulm Med 2005, 11:35-42.
11. Alam R., Stafford S., Forsythe P., et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993, 150:3442-3447.
12. Schall T.J., Bacon K., Toy K.J., et al. Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990, 347:669-671.
13. Sim T.C., Reece L.M., Hilsmeier K.A., et al. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995, 152:927-933.
14. Alam R., York J., Boyars M., et al. Increased MCP-1, RANTES and MIP-1 alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996, 153:1398-1404.
15. Zietkowski Z., Tomasiak M.M., Skiepko R., et al. RANTES in exhaled breath condensate of stable and unstable asthma patients. Respir Med 2008, 102:1198-1202.
16. Lukacs N.W., Strieter R.M., Warmington K., et al. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 1997, 158:4398-4404.
17. Lachheb J., Chelbi H., Hamzaoui K., et al. Association between RANTES polymorphisms and asthma severity among Tunisian children. Hum Immunol 2007, 68:675-680.
18. Fryer A.A., Spiteri M.A., Bianco A., et al. The -403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 2000, 1:509-514.
19. Muro M., Marin L., Torio A., et al. CCL5/RANTES chemokine gene promoter polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population. Int J Immunogenet 2008, 35:19-23.
20. Zhang Y.G., Huang J., Zhang J., et al. RANTES gene polymorphisms and asthma risk: a meta-analysis. Arch Med Res 2010, 41:50-58.
21. Campbell E.M., Charo I.F., Kunkel S.L., et al. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. J Immunol 1999, 163:2160-2167.
22. Gonzalo J.A., Lloyd C.M., Wen D., et al. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 1998, 188:157-167.
23. Smith D.L., Deshanzo R.D. Bronchial lavage in asthma. An update and perspective. Am Rev Respir Dis 1993, 148:523-532.
24. Pin I., Gibson P.G., Kolendowicz R. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992, 47:25-29.
25. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987, 136:225-244. American Thoracic Society.
26. Global Initiative for Asthma. Global strategy for asthma management and prevention 2002, National Institutes for Health and National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, NIH publication 02-3659.
27. Brown W.G., Halonen M.J., Kaltenborn W.T., et al. The relationship of respiratory allergy, skin test reactivity, and serum IgE in a community population sample. J Allergy Clin Immunol 1979, 63:328-335.
28. Locati M., Bonecchi R., Corsi M.M. Chemokines and their receptors: roles in specific clinical conditions and measurement in the clinical laboratory. Am J Clin Pathol 2005, (123 Suppl):S82-95.
29. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995, 152:1107-1136. American Thoracic Society.
30. Garcia G., Adler M., Humber M. Difficult asthma. Allergy 2003, 58:114-121.
31. Chung K.F., Barnes P.J. Cytokines in asthma. Thorax 1999, 54:825-857.
32. Barnes P.J. Cytokine modulators for allergic diseases. Curr Opin Allergy Clin Immunol 2001, 1:555-560.
33. Lun S.W., Wong C.K., Ko F.W., et al. Aberrant expression of CC and CXC chemokines and their receptors in patients with asthma. J Clin Immunol 2006, 26:145-152.
34. Chihara J., Yasuba H., Tsuda A., et al. Elevation of the plasma level of RANTES during asthma attacks. J Allergy Clin Immunol 1997, 100:S52-S55.
35. Ying S., Meng Q., Zeibecoglou K., et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999, 163:6321-6329.
36. Berkman N., Krishnan V.L., Gilbey T., et al. Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am J Respir Crit Care Med 1996, 154:1804-1811.
37. Powell N., Humbert M., Durham S.R., et al. Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur Respir J 1996, 9:2454-2460.
38. Tillie-Leblond I., Hammad H., Desurmont S., et al. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment. Am J Respir Crit Care Med 2000, 162:586-592.
39. Erten G., Musellim B., Tutluoglu B., et al. Peripheral blood lymphocyte activation and RANTES levels in asthma. Turk J Med Sci 2008, 38:531-536.
40. John M., Oltmanns U., Binder C., et al. Inhibition of chemokine production from human airway smooth muscle cells by fluticasone, budesonide and beclomethasone. Pulm Pharmacol Ther 2004, 17:41-47.
41. Teran L.M., Noso N., Carroll M., et al. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol 1996, 157:1806-1812.
42. Gauvreau G.M., Watson R.M., O'Byme P.M. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. Am J Respir Crit Care Med 1999, 160:640-647.
43. Boyce J.A. The pathobiology of eosinophilic inflammation. Allergy Asthma Proc 1997, 18:293-300.
44. Kuna P., Reddigari S.R., Schall T.J., et al. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol 1992, 149:636-642.
45. Kimata B.H., Yoshida A., Ishioka C., Furusho K., et al. RANTES and macrophage inflammatory protein 1 α selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J Exp Med 1996, 183:2397-2402.
46. Bacon K.B., Premack B.A., Gardner P., et al. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 1995, 269:1727-1729.
47. Yao T.C., Kuo M.L., See L.C., et al. The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children. J Allergy Clin Immunol 2003, 111:1285-1292.
48. Sohn M.H., Kim S.H., Kim K.W., et al. RANTES gene promoter polymorphisms are associated with bronchial hyperresponsiveness in Korean children with asthma. Lung 2008, 186:37-43.
49. de Boer W.I., Sont J.K., van Schadewijk A., et al. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 2000, 190:619-626.
50. Chan C.K., Kuo M.L., Yeh K.W., et al. Sequential evaluation of serum monocyte chemotactic protein 1 among asymptomatic state and acute exacerbation and remission of asthma in children. J Asthma 2009, 46:225-228.
51. Sousa A.R., Lane S.J., Nakhosteen J.A., et al. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol 1994, 10:142-147.
52. Kurashima K., Mukaida N., Fujimura M., et al. Increase of chemokine levels in sputum precedes exacerbation of acute asthma attacks. J Leukoc Biol 1996, 59:313-316.
53. Holgate S.T., Bodey K.S., Janezic A., et al. Release of RANTES, MIP-1α, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997, 156:1377-1383.
54. Folkard S.G., Westwick J., Millar A.B. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur Respir J 1997, 10:2097-2104.
55. Szalai C., Kozma G.T., Nagy A., et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001, 108:375-381.